✨ Free AI Report
COSMOS Pharmaceutical Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research COSMOS Pharmaceutical Corporation
Company Research

COSMOS Pharmaceutical Corporation: Business Overview, Financials & Competitive Analysis

COSMOS Pharmaceutical Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). Operationally strong retail pharmacy chain with solid earnings growth, but current valuation premium to peers limits near-term upside potential. COSMOS grew EBIT by 19% last year with a solid track record. However, the company trades at a P/E of 23.1x, significantly higher than the industry average of 13.8x, suggesting.

What is COSMOS Pharmaceutical Corporation's industry? COSMOS Pharmaceutical Corporation (cosmos-pharm.co.jp) operates in Consumer Retailing - Pharmacy & General Merchandise. AskCyborg classifies COSMOS Pharmaceutical Corporation under Consumer Retailing - Pharmacy & General Merchandise in its company registry.

COSMOS Pharmaceutical engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food and other products in Japan. The company sells products through retail stores and online channels. Founded in 198...

6/ 10Solid

Cyborg Score thesis

Operationally strong retail pharmacy chain with solid earnings growth, but current valuation premium to peers limits near-term...

Read the full analyst-debate transcript →
Industry Consumer Retailing - Pharmacy & General Merchandise
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest COSMOS Pharmaceutical Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for COSMOS Pharmaceutical Corporation

AskCyborg analysts argue the bull and bear cases for COSMOS Pharmaceutical Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
COSMOS Pharmaceutical Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

COSMOS Pharmaceutical Corporation Overview

Pro stress-test →

COSMOS Pharmaceutical engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food and other products in Japan. The company sells products through retail stores and online channels. Founded in 1983 and headquartered in Fukuoka, COSMOS operates a large network of retail locations across Japan, making it a significant player in the Japanese consumer retail pharmacy sector.

Strategic Profile

Pro stress-test →

The company employs IT solutions and logistics optimization across thousands of stores, reducing operational costs while ensuring timely restocking, supported by an "Everyday Low Pricing" strategy that drives volume sales. Shares have advanced 35% year-to-date with consistent revenue and net income increases, though recent valuations appear stretched.

Competitive Landscape

Pro stress-test →

COSMOS is covered by 18 analysts. The company competes in Japan's retail pharmacy and consumer goods sector dominated by major chains. Its scale, multi-category product offering (pharmaceuticals, cosmetics, health foods, daily necessities), and omnichannel distribution provide competitive advantages in a consolidated market.

Industry Context

COSMOS Pharmaceutical Corporation operates in Consumer Retailing - Pharmacy & General Merchandise.

Key facts

Founded: 1983 · Headquarters: Fukuoka, Japan · Revenue: ¥215.9B (Gross Profit - FY Aug 2025) · Market cap: ¥598.9B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on COSMOS Pharmaceutical Corporation.

  • Strong performance with shares up 35% year-to-date after consistent revenue and net income growth
  • Trading at expensive 23.1x P/E versus 13.8x industry average, raising valuation concerns
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Nov 2025EBIT grew 19% year-over-year with healthy balance sheet
  • Sep 2025Share price movement raising investor attention despite lack of major headline news
  • +1 moreTrack every material event for COSMOS Pharmaceutical Corporation as it happens. Explore monitoring →
Get alerted when COSMOS Pharmaceutical Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare COSMOS Pharmaceutical Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

COSMOS Pharmaceutical Corporation operates in Consumer Retailing - Pharmacy & General Merchandise. See how the rest of the sector scores on the Cyborg framework.

Browse Consumer Retailing - Pharmacy & General Merchandise research →
NEW · MCP server

Ask your AI assistant about COSMOS Pharmaceutical Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare COSMOS Pharmaceutical Corporation and its top competitor on Cyborg Score”
“What did COSMOS Pharmaceutical Corporation do this quarter?”
“Is COSMOS Pharmaceutical Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does COSMOS Pharmaceutical Corporation do?+
COSMOS Pharmaceutical engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food and other products in Japan. The company sells products through retail stores and online channels. Founded in 198...
What is COSMOS Pharmaceutical Corporation's Cyborg Score?+
COSMOS Pharmaceutical Corporation has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are COSMOS Pharmaceutical Corporation's main competitors?+
Named competitors include Pharmacy & Consumer Health Retail, Large-scale Discount Retail, Online Health & Beauty. The full competitive landscape is in the AskCyborg report.
How can I get the full COSMOS Pharmaceutical Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the COSMOS Pharmaceutical Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track COSMOS Pharmaceutical Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual